Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06056908 · ClinicalTrials.gov registry record
Shwachman Diamond Syndrome Registry and Study
A clinical trial of Shwachman-Diamond Syndrome and Shwachman-Diamond Syndrome-Like, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 4
- Study locations
NCT06056908: Recruiting study of Shwachman-Diamond Syndrome and Shwachman-Diamond Syndrome-Like, sponsored by Boston Children's Hospital.
NCT06056908 is a study of Shwachman-Diamond Syndrome and Shwachman-Diamond Syndrome-Like that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 5,000 participants, above the 4,007-participant average among 3 other Shwachman-Diamond Syndrome trials with a reported enrollment target (25% higher). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06056908, a study of Shwachman-Diamond Syndrome and Shwachman-Diamond Syndrome-Like, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
Shwachman-Diamond syndrome (SDS) is a genetic condition characterized by bone marrow failure, medical co-morbidities, and leukemia predisposition. SDS-Like patients share clinical features with SDS but lack mutations in known SDS genes. Since SDS/SDS-Like syndromes are rare diseases, data are sparse regarding the clinical features, natural history, clinical outcomes with current management, and treatment. For this reason, the SDS Registry was formed to collect clinical data from medical records and to bank biological samples with the goal of understanding SDS/SDS-Like diseases to develop better treatments and improve the health of patients with these conditions.
Primary Outcome
The SDSR will collect clinical information regarding SDS and SDS-Like conditions. The goal is to understand the natural history, treatment outcomes and complications of these rare disorders in order to improve diagnosis, medical management, and treatment.
Conditions Studied
Study Locations (4)
Massachusetts
- Boston Children's Hospital - Boston
- Dana-Farber Cancer Institute - Boston
Colorado
- Children's Hospital Colorado - Aurora
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2016-01-19 |
| Est. Completion | 2090-01-01 |
What NCT06056908 shows while recruiting
NCT06056908 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 4,007-participant average among 3 other Shwachman-Diamond Syndrome trials with a reported enrollment target (25% higher).
The record links to 2 conditions, with Shwachman-Diamond Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT06056908 reports a single indexed study location in Massachusetts, Colorado, Ohio.
Frequently Asked Questions
What is clinical trial NCT06056908 about?
NCT06056908 is a clinical study titled "Shwachman Diamond Syndrome Registry and Study". Shwachman-Diamond syndrome (SDS) is a genetic condition characterized by bone marrow failure, medical co-morbidities, and leukemia predisposition. SDS-Like patients share clinical features with SDS but lack mutations in known SDS genes. Since SDS/SDS-Like syndromes are rare diseases, data are sparse...
What is the current status of trial NCT06056908?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2016-01-19. Estimated completion is 2090-01-01.
What conditions does trial NCT06056908 study?
This clinical trial studies the following conditions: Shwachman-Diamond Syndrome, Shwachman-Diamond Syndrome-Like.
Who is sponsoring clinical trial NCT06056908?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06056908 being conducted?
This trial has 4 study locations across Colorado, Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shwachman-Diamond Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI